Next 10 |
home / stock / avcrf / avcrf news
2024-04-30 11:00:34 ET More on Avricore Health Financial information for Avricore Health Read the full article on Seeking Alpha For further details see: Avricore Health reports FY results
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross pr...
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTab™ with Rexall Pharmacy Group ULC (“Rexall...
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) reports on its third quarter results which demonstrate significant growth in pharmacy locations offering HealthTab driving strong revenue growth...
--News Direct-- Avricore Health CEO Hector Bremner joined Steve Darling from Proactive to share news regarding the company's flagship health-data management platform, HealthTab. The company has made a significant move by partnering with Rexall Pharmacy, one of Canada's largest pharmac...
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic and infectious disease screening and health-data management ...
--News Direct-- Avricore Health CEO Hector Bremner discussed the company's significant growth, partnerships, and expansion into new markets during an interview with Steve Darling from Proactive. Bremner shared how these developments position Avricore Health for future success, with a ...
VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) continues to achieve significant growth, new partnerships and developing new markets while surpassing margin targets. Now, as the Company looks ...
VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller agreement between HealthTab™ Inc. and Abbott Rapid Dx U...
--News Direct-- Avricore Health CEO Hector Bremner tells Proactive's Stephen Gunnion that HealthTab has been selected for a UK-based feasibility study, marking an important international expansion. Avricore Health has achieved success in Canada with HealthTab, the company's leading ph...
News, Short Squeeze, Breakout and More Instantly...
Avricore Health Inc. Company Name:
AVCRF Stock Symbol:
OTCMKTS Market:
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross pr...
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV:AVCR, OTC:AVCRF) ("Avricore Health" or the "Company"...
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTab™ with Rexall Pharmacy Group ULC (“Rexall...